{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:14:05Z","timestamp":1792444445824,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.neurol.2020.06.009","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:42:43Z","timestamp":1599759763000},"page":"245-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS)"],"prefix":"10.1016","volume":"177","author":[{"given":"M.F.","family":"Vecchierini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Kilic-Huck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Quera-Salva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2020.06.009_bib0430","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/S0021-9258(18)69351-2","article-title":"Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands","volume":"235","author":"Lerner","year":"1960","journal-title":"J Biol Chem"},{"issue":"3409","key":"10.1016\/j.neurol.2020.06.009_bib0435","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.131.3409.1312","article-title":"Enzymatic O-methylation of N-acetylserotonin to melatonin","volume":"131","author":"Axelrod","year":"1960","journal-title":"Science"},{"issue":"5242","key":"10.1016\/j.neurol.2020.06.009_bib0440","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1126\/science.270.5242.1681","article-title":"Pineal serotonin N-acetyltransferase: expression cloning and molecular analysis","volume":"270","author":"Coon","year":"1995","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neurol.2020.06.009_bib0445","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0748730405277232","article-title":"Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors","volume":"20","author":"Guillaumond","year":"2005","journal-title":"Journal of biological rhythms"},{"issue":"4764","key":"10.1016\/j.neurol.2020.06.009_bib0450","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.3726555","article-title":"Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle","volume":"233","author":"Czeisler","year":"1986","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0455","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/pr.110.002832","article-title":"International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors","volume":"62","author":"Dubocovich","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"13","key":"10.1016\/j.neurol.2020.06.009_bib0460","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/cne.22381","article-title":"Morphology and mosaics of melanopsin-expressing retinal ganglion cell types in mice","volume":"518","author":"Berson","year":"2010","journal-title":"J Comp Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0465","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00441-002-0580-5","article-title":"The anatomy and innervation of the mammalian pineal gland","volume":"309","author":"Moller","year":"2002","journal-title":"Cell and tissue research"},{"issue":"13","key":"10.1016\/j.neurol.2020.06.009_bib0470","first-page":"47","article-title":"Neural control of pineal function in mammals and birds","author":"Moore","year":"1978","journal-title":"J Neural Transm Suppl"},{"issue":"2\u20133","key":"10.1016\/j.neurol.2020.06.009_bib0475","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuchi.2015.03.002","article-title":"Melatonin: Physiological effects in humans","volume":"61","author":"Claustrat","year":"2015","journal-title":"Neuro-Chirurgie"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0480","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/07420528909059144","article-title":"The dim light melatonin onset as a marker for circadian phase position","volume":"6","author":"Lewy","year":"1989","journal-title":"Chronobiology Int"},{"issue":"16","key":"10.1016\/j.neurol.2020.06.009_bib0485","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/bph.14116","article-title":"New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation","volume":"175","author":"Zisapel","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smrv.2004.08.001","article-title":"The basic physiology and pathophysiology of melatonin","volume":"9","author":"Claustrat","year":"2005","journal-title":"Sleep Med Rev"},{"issue":"5","key":"10.1016\/j.neurol.2020.06.009_bib0495","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2217\/14622416.9.5.625","article-title":"Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms","volume":"9","author":"Gunes","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.neurol.2020.06.009_bib0500","first-page":"548","article-title":"Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin (R)) in insomnia","volume":"44","author":"Quera-Salva","year":"2018","journal-title":"Encephale-Revue De Psychiatrie Clinique Biologique Et Therapeutique"},{"issue":"2","key":"10.1016\/j.neurol.2020.06.009_bib0505","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjmed.2003.07.017","article-title":"Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy","volume":"116","author":"Leger","year":"2004","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0510","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-079X.2011.00962.x","article-title":"Melatonin and its analogs in insomnia and depression","volume":"52","author":"Cardinali","year":"2012","journal-title":"J Pineal Res"},{"issue":"6315","key":"10.1016\/j.neurol.2020.06.009_bib0515","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.aah4968","article-title":"Mechanisms linking circadian clocks, sleep, and neurodegeneration","volume":"354","author":"Musiek","year":"2016","journal-title":"Science"},{"issue":"5 Pt 2","key":"10.1016\/j.neurol.2020.06.009_bib0520","doi-asserted-by":"crossref","first-page":"S846","DOI":"10.1016\/S0013-7006(06)76241-8","article-title":"[Change in rhythms with age]","volume":"32","author":"Benoit","year":"2006","journal-title":"L\u2019Encephale"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0525","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-079X.1993.tb00498.x","article-title":"Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis","volume":"14","author":"Poeggeler","year":"1993","journal-title":"J Pineal Res"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0530","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157015910792246209","article-title":"Clinical aspects of melatonin intervention in Alzheimer's disease progression","volume":"8","author":"Cardinali","year":"2010","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"10.1016\/j.neurol.2020.06.009_bib0535","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/gps.760","article-title":"Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia","volume":"17","author":"Serfaty","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"10.1016\/j.neurol.2020.06.009_bib0540","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/sleep\/26.7.893","article-title":"A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease","volume":"26","author":"Singer","year":"2003","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.neurol.2020.06.009_bib0545","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/JGP.0b013e318187de18","article-title":"Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease","volume":"17","author":"Gehrman","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0550","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1272\/jnms.70.334","article-title":"Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia","volume":"70","author":"Asayama","year":"2003","journal-title":"J Nippon Med Sch"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0555","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00391-007-0420-z","article-title":"Actigraphy in agitated patients with dementia. Monitoring treatment outcomes","volume":"40","author":"Mahlberg","year":"2007","journal-title":"Zeitschrift fur Gerontologie und Geriatrie"},{"key":"10.1016\/j.neurol.2020.06.009_bib0560","first-page":"947","article-title":"Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial","volume":"9","author":"Wade","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"2","key":"10.1016\/j.neurol.2020.06.009_bib0565","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1532-5415.2007.01543.x","article-title":"Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease","volume":"56","author":"Dowling","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"22","key":"10.1016\/j.neurol.2020.06.009_bib0570","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1001\/jama.299.22.2642","article-title":"Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial","volume":"299","author":"Riemersma-van der Lek","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0575","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1081\/CBI-100101055","article-title":"Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons","volume":"17","author":"Mishima","year":"2000","journal-title":"Chronobiology Int"},{"key":"10.1016\/j.neurol.2020.06.009_bib0580","first-page":"CD009178","article-title":"Pharmacotherapies for sleep disturbances in dementia","volume":"11","author":"McCleery","year":"2016","journal-title":"The Cochrane database of systematic reviews"},{"issue":"5","key":"10.1016\/j.neurol.2020.06.009_bib0585","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1533317514568005","article-title":"Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials","volume":"30","author":"Xu","year":"2015","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0590","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10072-015-2357-0","article-title":"Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials","volume":"37","author":"Zhang","year":"2016","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0595","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/gps.4571","article-title":"Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease","volume":"32","author":"Wang","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0600","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-079X.1998.tb00557.x","article-title":"Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment","volume":"25","author":"Jean-Louis","year":"1998","journal-title":"J Pineal Res"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0605","first-page":"432","article-title":"Cognitive effects of exogenous melatonin administration in elderly persons: a pilot study","volume":"12","author":"Peck","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0610","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-079X.2007.00491.x","article-title":"Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study","volume":"43","author":"Furio","year":"2007","journal-title":"J Pineal Res"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0615","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF03324897","article-title":"Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study","volume":"21","author":"Garzon","year":"2009","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0620","first-page":"280","article-title":"Therapeutic application of melatonin in mild cognitive impairment","volume":"1","author":"Cardinali","year":"2012","journal-title":"Am J Neurodegenerative Dis"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0625","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1212\/WNL.36.4.576","article-title":"Olivopontocerebellar degeneration, abnormal sleep, and REM sleep without atonia","volume":"36","author":"Quera-Salva","year":"1986","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2020.06.009_bib0630","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","article-title":"Chronic behavioral disorders of human REM sleep: a new category of parasomnia","volume":"9","author":"Schenck","year":"1986","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0635","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0640","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.25026","article-title":"Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder","volume":"82","author":"Iranzo","year":"2017","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0645","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2869.2010.00848.x","article-title":"A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder","volume":"19","author":"Kunz","year":"2010","journal-title":"J Sleep Res"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0650","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.sleep.2014.09.011","article-title":"Melatonin therapy for REM sleep behavior disorder: a critical review of evidence","volume":"16","author":"McGrane","year":"2015","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.neurol.2020.06.009_bib0655","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000488893","article-title":"Twenty Years After: Another Case Report of Melatonin Effects on REM Sleep Behavior Disorder Using Serial Dopamine Transporter Imaging","volume":"76","author":"Kunz","year":"2017","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0660","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.sleep.2012.09.018","article-title":"Treatment outcomes in REM sleep behavior disorder","volume":"14","author":"McCarter","year":"2013","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0665","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5664\/jcsm.27717","article-title":"Best practice guide for the treatment of REM sleep behavior disorder (RBD)","volume":"6","author":"Aurora","year":"2010","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0670","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1532-5415.2012.03922.x","article-title":"2012 American Geriatrics Society Beers Criteria: new year, new criteria, new perspective","volume":"60","author":"Fick","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"10.1016\/j.neurol.2020.06.009_bib0675","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.sleep.2013.02.016","article-title":"Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.neurol.2020.06.009_bib0680","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","article-title":"Melatonin for sleep disturbances in Parkinson's disease","volume":"6","author":"Dowling","year":"2005","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0685","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","article-title":"Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study","volume":"254","author":"Medeiros","year":"2007","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2020.06.009_bib0690","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11910-016-0664-3","article-title":"Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases","volume":"16","author":"Trotti","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0695","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1526-4610.1989.hed22904242.x","article-title":"Nocturnal plasma melatonin levels in migraine: a preliminary report","volume":"29","author":"Claustrat","year":"1989","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0700","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10194-008-0047-5","article-title":"Low urinary 6-sulphatoxymelatonin concentrations in acute migraine","volume":"9","author":"Masruha","year":"2008","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0705","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s10194-018-0844-4","article-title":"PACAP in hypothalamic regulation of sleep and circadian rhythm: importance for headache","volume":"19","author":"Holland","year":"2018","journal-title":"J Headache Pain"},{"issue":"7","key":"10.1016\/j.neurol.2020.06.009_bib0710","doi-asserted-by":"crossref","first-page":"e13203","DOI":"10.1111\/ijcp.13203","article-title":"Melatonin for preventing primary headache: A systematic review","volume":"72","author":"Leite Pacheco","year":"2018","journal-title":"Int J Clin Pract"},{"issue":"8","key":"10.1016\/j.neurol.2020.06.009_bib0715","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/head.12862","article-title":"The Role of Melatonin in the Treatment of Primary Headache Disorders","volume":"56","author":"Gelfand","year":"2016","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0720","first-page":"47","article-title":"A Randomized Clinical Trial Comparing the Efficacy of Melatonin and Amitriptyline in Migraine Prophylaxis of Children","volume":"12","author":"Fallah","year":"2018","journal-title":"Iranian journal of child neurology"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0725","first-page":"385","article-title":"Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial","volume":"35","author":"Ebrahimi-Monfared","year":"2017","journal-title":"Restor Neurol Neurosci"},{"issue":"10","key":"10.1016\/j.neurol.2020.06.009_bib0730","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/jnnp-2016-313458","article-title":"Randomised clinical trial comparing melatonin 3mg, amitriptyline 25mg and placebo for migraine prevention","volume":"87","author":"Goncalves","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"17","key":"10.1016\/j.neurol.2020.06.009_bib0735","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1212\/WNL.0b013e3181f9618c","article-title":"Prophylaxis of migraine with melatonin: a randomized controlled trial","volume":"75","author":"Alstadhaug","year":"2010","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neurol.2020.06.009_bib0740","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1468-2982.1996.1607494.x","article-title":"Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups","volume":"16","author":"Leone","year":"1996","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0745","doi-asserted-by":"crossref","first-page":"e14099","DOI":"10.1097\/MD.0000000000014099","article-title":"Therapeutic role of melatonin in migraine prophylaxis: A systematic review","volume":"98","author":"Long","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.neurol.2020.06.009_bib0750","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eplepsyres.2018.08.013","article-title":"Neuroendocrine aspects of improving sleep in epilepsy","volume":"147","author":"Reddy","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neurol.2020.06.009_bib0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2015.05.031","article-title":"Chronotype in patients with epilepsy: A controlled study in 60 subjects with late-onset focal epilepsy","volume":"50","author":"Manni","year":"2015","journal-title":"Epilepsy & behavior: E&B"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0760","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1615\/JEnvironPatholToxicolOncol.2016016399","article-title":"Glutamate Excitotoxicity and Oxidative Stress in Epilepsy: Modulatory Role of Melatonin","volume":"35","author":"Vishnoi","year":"2016","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"5","key":"10.1016\/j.neurol.2020.06.009_bib0765","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.sleep.2015.01.005","article-title":"Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study","volume":"16","author":"Jain","year":"2015","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.neurol.2020.06.009_bib0770","first-page":"CD006967","article-title":"Melatonin as add-on treatment for epilepsy","author":"Brigo","year":"2012","journal-title":"The Cochrane database of systematic reviews"},{"issue":"6","key":"10.1016\/j.neurol.2020.06.009_bib0775","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.braindev.2003.09.008","article-title":"Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial","volume":"26","author":"Coppola","year":"2004","journal-title":"Brain Dev"},{"issue":"35","key":"10.1016\/j.neurol.2020.06.009_bib0780","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.2174\/0929867324666170718105557","article-title":"Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders","volume":"24","author":"Sanchez-Barcelo","year":"2017","journal-title":"Curr Med Chem"},{"issue":"7538","key":"10.1016\/j.neurol.2020.06.009_bib0785","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.38731.532766.F6","article-title":"Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis","volume":"332","author":"Buscemi","year":"2006","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0790","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/jpn.0324","article-title":"Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study","volume":"28","author":"Almeida Montes","year":"2003","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"10.1016\/j.neurol.2020.06.009_bib0795","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2869.2007.00613.x","article-title":"Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects","volume":"16","author":"Lemoine","year":"2007","journal-title":"J Sleep Res"},{"issue":"5","key":"10.1016\/j.neurol.2020.06.009_bib0800","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/YIC.0b013e32832e9b08","article-title":"The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia","volume":"24","author":"Luthringer","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.neurol.2020.06.009_bib0805","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1741-7015-8-51","article-title":"Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety","volume":"8","author":"Wade","year":"2010","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0810","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1185\/03007995.2010.537317","article-title":"Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response","volume":"27","author":"Wade","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0815","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/YIC.0000000000000046","article-title":"Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin","volume":"30","author":"Hajak","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0820","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1517\/14728214.2012.690735","article-title":"Drugs for insomnia","volume":"17","author":"Zisapel","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0825","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.smrv.2004.06.004","article-title":"Effects of exogenous melatonin on sleep: a meta-analysis","volume":"9","author":"Brzezinski","year":"2005","journal-title":"Sleep Med rev"},{"issue":"5","key":"10.1016\/j.neurol.2020.06.009_bib0830","doi-asserted-by":"crossref","first-page":"e63773","DOI":"10.1371\/journal.pone.0063773","article-title":"Meta-analysis: melatonin for the treatment of primary sleep disorders","volume":"8","author":"Ferracioli-Oda","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.neurol.2020.06.009_bib0835","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.smrv.2016.06.005","article-title":"Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders","volume":"34","author":"Auld","year":"2017","journal-title":"Sleep Med Rev"},{"issue":"3","key":"10.1016\/j.neurol.2020.06.009_bib0840","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/YIC.0b013e32832c260b","article-title":"A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6mg) or placebo for sleep disturbance and depressed mood","volume":"25","author":"Serfaty","year":"2010","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.neurol.2020.06.009_bib0845","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4088\/JCP.v61n0509","article-title":"Melatonin improves sleep quality of patients with chronic schizophrenia","volume":"61","author":"Shamir","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.neurol.2020.06.009_bib0850","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2125.2008.03320.x","article-title":"The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study)","volume":"67","author":"Koch","year":"2009","journal-title":"Br J Clin Pharmacol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720306561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720306561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:42:32Z","timestamp":1758519752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378720306561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0035378720306561"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.06.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS)","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}